Cargando…
Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System
Lipid metabolism is altered in several cancer settings leading to different ratios of intermediates. Ovarian cancer is the most lethal gynecological malignancy. Cancer cells disperse in the abdominal space and ascites occurs. T cells obtained from ascites are unable to proliferate after an antigenic...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796219/ https://www.ncbi.nlm.nih.gov/pubmed/29342108 http://dx.doi.org/10.3390/ijms19010273 |
_version_ | 1783297461086846976 |
---|---|
author | Wefers, Christina Duiveman-de Boer, Tjitske Zusterzeel, Petra L. M. Massuger, Leon F. A. G. Fuchs, David Torensma, Ruurd Wheelock, Craig E. de Vries, I. Jolanda M. |
author_facet | Wefers, Christina Duiveman-de Boer, Tjitske Zusterzeel, Petra L. M. Massuger, Leon F. A. G. Fuchs, David Torensma, Ruurd Wheelock, Craig E. de Vries, I. Jolanda M. |
author_sort | Wefers, Christina |
collection | PubMed |
description | Lipid metabolism is altered in several cancer settings leading to different ratios of intermediates. Ovarian cancer is the most lethal gynecological malignancy. Cancer cells disperse in the abdominal space and ascites occurs. T cells obtained from ascites are unable to proliferate after an antigenic stimulus. The proliferation of ascites-derived T cells can be restored after culturing the cells for ten days in normal culture medium. No pathway aberrancies were detected. The acellular fraction of ascites can inhibit the proliferation of autologous as well as allogeneic peripheral blood lymphocytes, indicating the presence of soluble factors that interfere with T cell functionality. Therefore, we analyzed 109 lipid mediators and found differentially regulated lipids in suppressive ascitic fluid compared to normal abdominal fluid. Our study indicates the presence of lipid intermediates in ascites of ovarian cancer patients, which coincidences with T cell dysfunctionality. Since the immune system in the abdominal cavity is compromised, this may explain the high seeding efficiency of disseminated tumor cells. Further research is needed to fully understand the correlation between the various lipids and T cell proliferation, which could lead to new treatment options. |
format | Online Article Text |
id | pubmed-5796219 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-57962192018-02-09 Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System Wefers, Christina Duiveman-de Boer, Tjitske Zusterzeel, Petra L. M. Massuger, Leon F. A. G. Fuchs, David Torensma, Ruurd Wheelock, Craig E. de Vries, I. Jolanda M. Int J Mol Sci Article Lipid metabolism is altered in several cancer settings leading to different ratios of intermediates. Ovarian cancer is the most lethal gynecological malignancy. Cancer cells disperse in the abdominal space and ascites occurs. T cells obtained from ascites are unable to proliferate after an antigenic stimulus. The proliferation of ascites-derived T cells can be restored after culturing the cells for ten days in normal culture medium. No pathway aberrancies were detected. The acellular fraction of ascites can inhibit the proliferation of autologous as well as allogeneic peripheral blood lymphocytes, indicating the presence of soluble factors that interfere with T cell functionality. Therefore, we analyzed 109 lipid mediators and found differentially regulated lipids in suppressive ascitic fluid compared to normal abdominal fluid. Our study indicates the presence of lipid intermediates in ascites of ovarian cancer patients, which coincidences with T cell dysfunctionality. Since the immune system in the abdominal cavity is compromised, this may explain the high seeding efficiency of disseminated tumor cells. Further research is needed to fully understand the correlation between the various lipids and T cell proliferation, which could lead to new treatment options. MDPI 2018-01-17 /pmc/articles/PMC5796219/ /pubmed/29342108 http://dx.doi.org/10.3390/ijms19010273 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Wefers, Christina Duiveman-de Boer, Tjitske Zusterzeel, Petra L. M. Massuger, Leon F. A. G. Fuchs, David Torensma, Ruurd Wheelock, Craig E. de Vries, I. Jolanda M. Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System |
title | Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System |
title_full | Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System |
title_fullStr | Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System |
title_full_unstemmed | Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System |
title_short | Different Lipid Regulation in Ovarian Cancer: Inhibition of the Immune System |
title_sort | different lipid regulation in ovarian cancer: inhibition of the immune system |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796219/ https://www.ncbi.nlm.nih.gov/pubmed/29342108 http://dx.doi.org/10.3390/ijms19010273 |
work_keys_str_mv | AT weferschristina differentlipidregulationinovariancancerinhibitionoftheimmunesystem AT duivemandeboertjitske differentlipidregulationinovariancancerinhibitionoftheimmunesystem AT zusterzeelpetralm differentlipidregulationinovariancancerinhibitionoftheimmunesystem AT massugerleonfag differentlipidregulationinovariancancerinhibitionoftheimmunesystem AT fuchsdavid differentlipidregulationinovariancancerinhibitionoftheimmunesystem AT torensmaruurd differentlipidregulationinovariancancerinhibitionoftheimmunesystem AT wheelockcraige differentlipidregulationinovariancancerinhibitionoftheimmunesystem AT devriesijolandam differentlipidregulationinovariancancerinhibitionoftheimmunesystem |